ajm300 and Long-QT-Syndrome

ajm300 has been researched along with Long-QT-Syndrome* in 1 studies

Trials

1 trial(s) available for ajm300 and Long-QT-Syndrome

Article	Year
Appraisal of ICH E14/S7B Q&As adopted in February 2022 using thorough QT/QTc study data for α4-integrin antagonist carotegrast methyl in Japanese healthy subjects. Journal of pharmacological sciences, 2022, Volume: 150, Issue:3 Topics: Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Fluoroquinolones; Healthy Volunteers; Heart Rate; Humans; Integrin alpha4; Japan; Long QT Syndrome; Moxifloxacin; Phenylalanine; Quinazolinones	2022

Article

Year

Appraisal of ICH E14/S7B Q&As adopted in February 2022 using thorough QT/QTc study data for α4-integrin antagonist carotegrast methyl in Japanese healthy subjects.

Journal of pharmacological sciences, 2022, Volume: 150, Issue:3

Topics: Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Fluoroquinolones; Healthy Volunteers; Heart Rate; Humans; Integrin alpha4; Japan; Long QT Syndrome; Moxifloxacin; Phenylalanine; Quinazolinones

2022